Literature DB >> 12734278

Extended-spectrum beta-lactamase enzymes in clinical isolates of Enterobacter species from Lagos, Nigeria.

I E Aibinu1, V C Ohaegbulam, E A Adenipekun, F T Ogunsola, T O Odugbemi, B J Mee.   

Abstract

Over a 9-month period, 8 of 40 nonduplicate isolates of Enterobacter spp. producing extended-spectrum beta-lactamase (ESBL) were detected for the first time from two hospitals in Lagos, Nigeria. Microbiologic and molecular analysis confirmed the presence of ESBL. Only four isolates transferred ESBL resistance as determined by the conjugation test, and pulsed-field gel electrophoresis showed genetically unrelated isolates.

Mesh：

Substances：

Year:  2003        PMID： 12734278      PMCID： PMC154721          DOI： 10.1128/JCM.41.5.2197-2200.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  30 in total

1.  Enterobacter in hospital.

Authors:  F R Falkiner
Journal:  J Hosp Infect       Date:  1992-03       Impact factor: 3.926

2.  Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum beta-lactamase TEM-9 (RHH-1) of Klebsiella pneumoniae.

Authors:  C Mabilat; S Goussard; W Sougakoff; R C Spencer; P Courvalin
Journal:  Plasmid       Date:  1990-01       Impact factor: 3.466

3.  Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae.

Authors:  C Neuwirth; E Siebor; J Lopez; A Pechinot; A Kazmierczak
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 4.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

5.  Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli.

Authors:  G A Jacoby; P Han
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

6.  Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System.

Authors:  D R Burwen; S N Banerjee; R P Gaynes
Journal:  J Infect Dis       Date:  1994-12       Impact factor: 5.226

7.  In-vitro activity of cefepime and other antimicrobials: survey of European isolates.

Authors:  C Thornsberry; S D Brown; Y C Yee; S K Bouchillon; J K Marler; T Rich
Journal:  J Antimicrob Chemother       Date:  1993-11       Impact factor: 5.790

Review 8.  beta-Lactam resistance amongst Enterobacter species.

Authors:  A F Ehrhardt; C C Sanders
Journal:  J Antimicrob Chemother       Date:  1993-11       Impact factor: 5.790

9.  Concomitant dissemination of three extended-spectrum beta-lactamases among different Enterobacteriaceae isolated in a French hospital.

Authors:  C de Champs; D Sirot; C Chanal; M C Poupart; M P Dumas; J Sirot
Journal:  J Antimicrob Chemother       Date:  1991-04       Impact factor: 5.790

10.  [Nosocomial bacteremia caused by Enterobacter spp.: epidemiology and prognostic factors].

Authors:  C Peña; M Pujol; R Pallarés; M Cisnal; J Ariza; F Gudiol
Journal:  Enferm Infecc Microbiol Clin       Date:  1993-10       Impact factor: 1.731
View more
  20 in total

1.  In vitro antimicrobial activity of crude extracts from plants Bryophyllum pinnatum and Kalanchoe crenata.

Authors:  Odunayo R Akinsulire; Ibukun E Aibinu; Tayo Adenipekun; Toyin Adelowotan; Tolu Odugbemi
Journal:  Afr J Tradit Complement Altern Med       Date:  2007-02-16

2.  High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.

Authors:  Véronique Duval; Ibrahim Maiga; Aminata Maiga; Thomas Guillard; Lucien Brasme; Dominique Forte; Janick Madoux; Véronique Vernet-Garnier; Christophe De Champs
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

3.  Characterization of Extended-Spectrum Beta-lactamase from Escherichia coli and Klebsiella Species from North Eastern Nigeria.

Authors:  Yahaya Mohammed; Galadima Bala Gadzama; Sambo Bello Zailani; Aaron Oladipo Aboderin
Journal:  J Clin Diagn Res       Date:  2016-02-01

4.  High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania.

Authors:  Bjørn Blomberg; Roland Jureen; Karim P Manji; Bushir S Tamim; Davis S M Mwakagile; Willy K Urassa; Maulidi Fataki; Viola Msangi; Marit G Tellevik; Samwel Y Maselle; Nina Langeland
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

5.  Evaluation of the antimicrobial properties of different parts of Citrus aurantifolia (lime fruit) as used locally.

Authors:  Ibukun Aibinu; Tayo Adenipekun; Toyin Adelowotan; Tolu Ogunsanya; Tolu Odugbemi
Journal:  Afr J Tradit Complement Altern Med       Date:  2006-11-13

6.  First description of Escherichia coli producing CTX-M-15- extended spectrum beta lactamase (ESBL) in out-patients from south eastern Nigeria.

Authors:  Ifeanyichukwu R Iroha; Charles O Esimone; Sandra Neumann; Lennart Marlinghaus; Miriam Korte; Florian Szabados; Sören Gatermann; Martin Kaase
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-07-23       Impact factor: 3.944

7.  bla CTX-M-I group extended spectrum beta lactamase-producing Salmonella typhi from hospitalized patients in Lagos, Nigeria.

Authors:  Kabiru O Akinyemi; Bamidele A Iwalokun; Olajide O Alafe; Sulaiman A Mudashiru; Christopher Fakorede
Journal:  Infect Drug Resist       Date:  2015-05-11       Impact factor: 4.003

8.  A Multicenter Study of Beta-Lactamase Resistant Escherichia coli and Klebsiella pneumoniae Reveals High Level Chromosome Mediated Extended Spectrum β Lactamase Resistance in Ogun State, Nigeria.

Authors:  Folasoge A Adeyankinnu; Babatunde O Motayo; Akinniyi Akinduti; John Akinbo; Joseph I Ogiogwa; Bukola W Aboderin; R A Agunlejika
Journal:  Interdiscip Perspect Infect Dis       Date:  2014-03-24

9.  Characterization of ESBL (SHV-12) producing clinical isolate of Enterobacter aerogenes from a tertiary care hospital in Nigeria.

Authors:  Murat Kasap; Kayode Fashae; Sinem Torol; Fetiye Kolayli; Fatma Budak; Haluk Vahaboglu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-01-12       Impact factor: 3.944

10.  Abattoirs as non-hospital source of extended spectrum beta lactamase producers: confirmed by the double disc synergy test and characterized by matrix-assisted laser desorption/ionization time of flight mass spectrometry.

Authors:  Moses Nkechukwu Ikegbunam; Linda Onyeka Anagu; Ifeanyi R Iroha; Chika Ebiye Ejikeugwu; Charles Okey Esimone
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.